Evidence map›Paper›PMID 22560291›Full record

ArticleAlcohol (Fayetteville, N.Y.)2012

Positive allosteric modulation of the GABA(B) receptor by GS39783 attenuates the locomotor stimulant actions of ethanol and potentiates the induction of locomotor sensitization.

Lauren C Kruse, David N Linsenbardt, Stephen L Boehm

Open access · greenAbstract read
In one paragraph

Article in Alcohol (Fayetteville, N.Y.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. GABACurrent topics in behavioral neurosciences · 2022
    Article
  4. The Novel Positive Allosteric Modulator of the GABAFrontiers in cell and developmental biology · 2021
    Article
  5. Article
  6. Potential of GABACNS drugs · 2019
    Review
  7. Article
  8. Article
  9. Reversal of morphine analgesic tolerance by ethanol in the mouse.The Journal of pharmacology and experimental therapeutics · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lauren C KruseDepartment of Psychology, Indiana Alcohol Research Center, Indiana University-Purdue University Indianapolis, Indianapolis, IN, USA.
David N Linsenbardt
Stephen L Boehm
Indiana University – Purdue University Indianapolis · US

Funding

TRAINING GRANT ON GENETICS ASPECTS OF ALCOHOLISMT32AA007462 · NIAAA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI CRISTINE L CZACHOWSKI · 1985 to 2026
$10.7M
GABAergic Mechanisms in the Modulation of Binge-Like Ethanol Intake in MiceR01AA016789 · NIAAA · STATE UNIVERSITY OF NY,BINGHAMTON · PI BOEHM, STEPHEN LEE · 2009 to 2013
$1.8M
Role of GABA-A alpha1 in Locomotor Sensitization to EthanolK01AA015434 · NIAAA · STATE UNIVERSITY OF NY,BINGHAMTON · PI BOEHM, STEPHEN LEE · 2005 to 2009
$762k
NIAAA NIH HHS AA015434NIAAA NIH HHS AA016789NIAAA NIH HHS AA07462NIAAA NIH HHS K01 AA015434NIAAA NIH HHS R01 AA016789NIAAA NIH HHS T32 AA007462
6 · The paper itself

Abstract

Acute ethanol-induced locomotor stimulation and ethanol-induced locomotor sensitization are two behavioral assays thought to model the rewarding effects of ethanol. Recent evidence suggests that GS39783, a GABA(B) positive allosteric modulator, may be effective at reducing both the rewarding and reinforcing effects of several drugs of abuse, including ethanol. The goal of this study was to determine if GS39783 was capable of altering acute ethanol-induced stimulation, and the induction and expression of ethanol-induced locomotor sensitization, without effecting basal locomotion levels. Several doses of GS39783 (ranging from 0 to 100 mg/kg, depending on experiment) were tested on adult male DBA/2J mice in four experiments using 3-day basal locomotion and acute ethanol stimulation paradigms, and 14-day induction and expression of ethanol sensitization paradigms. The results of experiment 1 are in agreement with current literature, suggesting that 30 mg/kg doses of GS39783 and lower do not alter basal locomotor activity. In experiment 2, we found that GS39783 significantly decreased acute ethanol stimulation, but only at the 30 mg/kg dose, supporting our hypothesis and other publications suggesting that GABA(B) receptors modulate acute ethanol stimulation. Contrary to our hypothesis, GS39783 did not alter the expression of locomotor sensitization. Additionally, repeated administration of GS39783 in conjunction with ethanol unexpectedly potentiated ethanol-induced locomotor sensitization. Further study of GS39783 is warranted as it may be a more tolerable treatment for alcoholism than full agonists, due to its behavioral efficacy at doses that lack sedative side effects. Our results add to current literature suggesting that the GABA(B) receptor system is indeed involved in the modulation of ethanol-induced locomotor stimulation and sensitization.

Indexed as

AnimalsCyclopentanesDrug SynergismEthanolMaleMiceMice, Inbred DBAMotor ActivityPyrimidinesReceptors, GABA-BCyclopentanesEthanolN,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diaminePyrimidinesReceptors, GABA-B

Identifiers

PMID22560291
PMCPMC3389305
OpenAlexW2109345760

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.